BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11665600)

  • 1. Expression, purification, and assay of cytosolic (catalytic) domains of membrane-bound mammalian adenylyl cyclases.
    Hatley ME; Gilman AG; Sunahara RK
    Methods Enzymol; 2002; 345():127-40. PubMed ID: 11665600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the two cytosolic domains of mammalian adenylyl cyclase.
    Whisnant RE; Gilman AG; Dessauer CW
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6621-5. PubMed ID: 8692867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of soluble adenylyl cyclase from human membrane-bound type 7 adenylyl cyclase.
    Yan SZ; Tang WJ
    Methods Enzymol; 2002; 345():231-41. PubMed ID: 11665607
    [No Abstract]   [Full Text] [Related]  

  • 4. A guanylyl cyclase from Paramecium with 22 transmembrane spans. Expression of the catalytic domains and formation of chimeras with the catalytic domains of mammalian adenylyl cyclases.
    Linder JU; Hoffmann T; Kurz U; Schultz JE
    J Biol Chem; 2000 Apr; 275(15):11235-40. PubMed ID: 10753932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a soluble adenylyl cyclase activated by Gs alpha and forskolin.
    Tang WJ; Gilman AG
    Science; 1995 Jun; 268(5218):1769-72. PubMed ID: 7792604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization of complex between soluble domains of adenylyl cyclase and activated Gs alpha.
    Tesmer JJ; Sunahara RK; Fancy DA; Gilman AG; Sprang SR
    Methods Enzymol; 2002; 345():198-206. PubMed ID: 11665605
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of forskolin interactions with type I, II, V, and VI adenylyl cyclases by Gs alpha.
    Sutkowski EM; Tang WJ; Broome CW; Robbins JD; Seamon KB
    Biochemistry; 1994 Nov; 33(43):12852-9. PubMed ID: 7947691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of forskolin and ATP with the cytosolic domains of mammalian adenylyl cyclase.
    Dessauer CW; Scully TT; Gilman AG
    J Biol Chem; 1997 Aug; 272(35):22272-7. PubMed ID: 9268376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of a soluble form of mammalian adenylyl cyclase.
    Dessauer CW; Gilman AG
    J Biol Chem; 1996 Jul; 271(28):16967-74. PubMed ID: 8663304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytosolic adenylyl cyclase defines a unique signaling molecule in mammals.
    Buck J; Sinclair ML; Schapal L; Cann MJ; Levin LR
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):79-84. PubMed ID: 9874775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two cytoplasmic domains of mammalian adenylyl cyclase form a Gs alpha- and forskolin-activated enzyme in vitro.
    Yan SZ; Hahn D; Huang ZH; Tang WJ
    J Biol Chem; 1996 May; 271(18):10941-5. PubMed ID: 8631912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CyaG, a novel cyanobacterial adenylyl cyclase and a possible ancestor of mammalian guanylyl cyclases.
    Kasahara M; Unno T; Yashiro K; Ohmori M
    J Biol Chem; 2001 Mar; 276(13):10564-9. PubMed ID: 11134014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the nucleotidyl cyclase helical domain in catalytically active dimer formation.
    Vercellino I; Rezabkova L; Olieric V; Polyhach Y; Weinert T; Kammerer RA; Jeschke G; Korkhov VM
    Proc Natl Acad Sci U S A; 2017 Nov; 114(46):E9821-E9828. PubMed ID: 29087332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of constitutively active mutants of mammalian adenylyl cyclase.
    Hatley ME; Benton BK; Xu J; Manfredi JP; Gilman AG; Sunahara RK
    J Biol Chem; 2000 Dec; 275(49):38626-32. PubMed ID: 10982815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Galpha i-mediated inhibition of type V adenylyl cyclase.
    Dessauer CW; Chen-Goodspeed M; Chen J
    J Biol Chem; 2002 Aug; 277(32):28823-9. PubMed ID: 12058044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of forskolin-insensitive to forskolin-sensitive (mouse-type IX) adenylyl cyclase.
    Yan SZ; Huang ZH; Andrews RK; Tang WJ
    Mol Pharmacol; 1998 Feb; 53(2):182-7. PubMed ID: 9463474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An isoform-specific interaction of the membrane anchors affects mammalian adenylyl cyclase type V activity.
    Seebacher T; Linder JU; Schultz JE
    Eur J Biochem; 2001 Jan; 268(1):105-10. PubMed ID: 11121109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analyses of type V adenylyl cyclase.
    Patel TB; Wittpoth C; Barbier AJ; Yigzaw Y; Scholich K
    Methods Enzymol; 2002; 345():160-87. PubMed ID: 11665603
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression and purification of soluble adenylyl cyclase from Escherichia coli.
    Beeler JA; Tang WJ
    Methods Mol Biol; 2004; 237():39-53. PubMed ID: 14501037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate specificity determinants of class III nucleotidyl cyclases.
    Bharambe NG; Barathy DV; Syed W; Visweswariah SS; Colaςo M; Misquith S; Suguna K
    FEBS J; 2016 Oct; 283(20):3723-3738. PubMed ID: 27542992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.